Ajax-Loading

Sino Biopharmaceutical Ltd - Operating Return On Assets

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.

The item "Operating-Return-On-Assets" stands at 8.79 percent as of 06/30/2025, the lowest value since 03/31/2024.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Operating Return On Assets" stands at 8.79 Percent. This represents a decrease of -0.12 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.3627 percentage points compared to the value the year prior.
The 1 year change in percentage points is -0.3627.
The 3 year change in percentage points is 1.18.

The Serie's long term average value is 8.51 percent. It's latest available value, on 06/30/2025, is 0.277 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2023, to it's latest available value, on 06/30/2025, is +2.62.
The Serie's change in percentage points from it's maximum value, on 09/30/2024, to it's latest available value, on 06/30/2025, is -2.15.

Operating Return On Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Operating Return On Assets905,699,262,464.00
LogoJohnson & Johnson - Operating Return On Assets486,508,953,600.00
LogoAbbVie Inc - Operating Return On Assets399,570,305,024.00
LogoRoche Holding AG - Operating Return On Assets317,433,206,677.55
LogoAstraZeneca PLC - Operating Return On Assets280,205,508,085.11